Evidence map›Paper›PMID 26215849›Full record

ArticleBritish journal of haematology2016

Characteristics of human primary mantle cell lymphoma engraftment in NSG mice.

Sunil Iyengar, Linda Ariza-McNaughton, Andrew Clear, David Taussig, Rebecca Auer, Amy Roe, Debra Lillington, Sameena Iqbal, Simon Joel, John Gribben and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sunil IyengarDepartment of Haemato-Oncology, Royal Marsden Hospital, Sutton, UK.
Linda Ariza-McNaughtonBarts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, UK.
Andrew ClearHaematopoeitic stem cell laboratory, The Francis Crick Institute, Lincoln's Inn Fields, London, UK.
David TaussigDepartment of Haemato-Oncology, Royal Marsden Hospital, Sutton, UK.
Rebecca AuerHaematopoeitic stem cell laboratory, The Francis Crick Institute, Lincoln's Inn Fields, London, UK.
Amy RoeCytogenetics Department, Barts Health NHS Trust, The Royal London Hospital, London, UK.
Debra LillingtonCytogenetics Department, Barts Health NHS Trust, The Royal London Hospital, London, UK.
Sameena IqbalHaematopoeitic stem cell laboratory, The Francis Crick Institute, Lincoln's Inn Fields, London, UK.
Simon JoelHaematopoeitic stem cell laboratory, The Francis Crick Institute, Lincoln's Inn Fields, London, UK.
John GribbenHaematopoeitic stem cell laboratory, The Francis Crick Institute, Lincoln's Inn Fields, London, UK.
Dominique BonnetBarts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, UK. dominique.bonnet@crick.ac.uk.

Funding

Cancer Research UK 15692
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsHeterograftsHumansLymphoma, Mantle-CellMiceMice, Inbred NODMice, SCIDNeoplasm Transplantationintravenous injectionmantle cell linesmantle cell primary samplesxenotransplantation

Identifiers

PMID26215849
PMCPMC4879502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.